Abolishing Dopamine D2long/D3 Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2 Receptor Agonists.

Journal of Medicinal Chemistry
Katharina TropmannAndrea Strasser

Abstract

3-(2-Amino-4-methylthiazol-5-yl)propyl-substituted carbamoylguanidines are potent, subtype-selective histamine H2 receptor (H2R) agonists, but their applicability as pharmacological tools to elucidate the largely unknown H2R functions in the central nervous system (CNS) is compromised by their concomitant high affinity toward dopamine D2-like receptors (especially to the D3R). To improve the selectivity, a series of novel carbamoylguanidine-type ligands containing various heterocycles, spacers, and side residues were rationally designed, synthesized, and tested in binding and/or functional assays at H1-4 and D2long/3 receptors. This study revealed a couple of selective candidates (among others 31 and 47), and the most promising ones were screened at several off-target receptors, showing good selectivities. Docking studies suggest that the amino acid residues (3.28, 3.32, E2.49, E2.51, 5.42, and 7.35) are responsible for the different affinities at the H2- and D2long/3-receptors. These results provide a solid base for the exploration of the H2R functions in the brain in further studies.

References

Jan 1, 1988·Psychopharmacology·J M White, G R Rumbold
Apr 21, 1972·Nature·J W BlackE M Parsons
Sep 15, 1994·Biochemical and Biophysical Research Communications·K OhtaH Fukui
May 1, 1999·Journal of the Neurological Sciences·J P Bennett, M F Piercey
Jun 1, 1999·Journal of Neurochemistry·N Sartania, P G Strange
Oct 9, 1999·The Journal of Biological Chemistry·K WielandR Leurs
Oct 24, 2001·The Journal of Organic Chemistry·Hugo E. GottliebAbraham Nudelman
Mar 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Roland SeifertSigurd Elz
Nov 17, 2004·Mini Reviews in Medicinal Chemistry·Stefan DoveArmin Buschauer
Jan 6, 2006·The Journal of Pharmacology and Experimental Therapeutics·Sheng-Xue XieRoland Seifert
Nov 16, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Heinz H PertzAndrea Strasser
Oct 12, 2007·The Journal of Pharmacology and Experimental Therapeutics·Andrea StrasserRoland Seifert
Mar 24, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Tom H JohnstonSusan H Fox
Apr 23, 2010·Bioorganic & Medicinal Chemistry Letters·Prasanta GhoraiArmin Buschauer
Aug 7, 2010·Biochemical Pharmacology·David SchnellRoland Seifert
Jul 13, 2011·Journal of Receptor and Signal Transduction Research·Nathalie PopArmin Buschauer
Jul 21, 2011·Nature·Søren G F RasmussenBrian K Kobilka
May 29, 2013·Journal of Visualized Experiments : JoVE·Sarah L DeVos, Timothy M Miller
Jun 15, 2013·Journal of Clinical Psychopharmacology·Katarina MeskanenJesper Ekelund
Mar 26, 2014·Neuroscience and Biobehavioral Reviews·Erich H SchneiderRoland Seifert

❮ Previous
Next ❯

Citations

Sep 19, 2021·The Journal of Pharmacology and Experimental Therapeutics·Ulrich GergsJoachim Neumann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.